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Semaphorins and their receptors (plexins) are axon-
guiding molecules that regulate the development of
the nervous system during embryogenesis. Here we
describe a previously unknown role of class 3 sema-
phorin E (Sema3E) in adipose tissue inflammation
and insulin resistance. Expression of Sema3E and
its receptor plexinD1 was upregulated in the adipose
tissue of a mouse model of dietary obesity. Inhibition
of the Sema3E-plexinD1 axis markedly reduced adi-
pose tissue inflammation and improved insulin resis-
tance in this model. Conversely, overexpression of
Sema3E in adipose tissue provoked inflammation
and insulin resistance. Sema3E promoted infiltration
of macrophages, and this effect was inhibited by
disrupting plexinD1 expression in macrophages.
Disruption of adipose tissue p53 expression led to
downregulation of Sema3E expression and improved
adipose tissue inflammation. These results indicate
that Sema3E acts as a chemoattractant for macro-
phages, with p53-induced upregulation of Sema3E
expression provoking adipose tissue inflammation
and systemic insulin resistance in association with
dietary obesity.
INTRODUCTION
The number of obese or diabetic patients has dramatically
increased in the modern world, and diabetes has become one
of the major health problems for many societies (Van Gaal
et al., 2006; Yanovski and Yanovski, 2002). There is accumu-
lating evidence that adipose tissue inflammation associated
with obesity is involved in the development and progression of
systemic insulin resistance and diabetes mellitus (Donath andCellShoelson, 2011; Hotamisligil, 2006). An excess of free fatty acids
and increased production of reactive oxygen species (ROS)
induce an inflammatory response in obese adipose tissue that
is characterized by infiltration of inflammatory cells and produc-
tion of proinflammatory cytokines such as tumor necrosis factor
(TNF)-a and chemokine (C–Cmotif) ligand 2 (CCL2), which is also
known as monocyte chemoattractant protein-1 (MCP-1) (Furu-
kawa et al., 2004; Lin et al., 2005; Minamino et al., 2009;
Weisberg et al., 2003). Overproduction of CCL2 attracts macro-
phages to adipose tissue and further increases the production of
proinflammatory molecules, which accelerates the vicious cycle
promoting inflammation during adipose tissue remodeling
(Kamei et al., 2006; Kanda et al., 2006; Sun et al., 2011). It has
been suggested that an increase of circulating proinflammatory
cytokines derived from inflamed adipose tissue interferes with
insulin signaling in key organs such as the skeletal muscle and
liver, leading to systemic insulin resistance and diabetes mellitus
(Schenk et al., 2008).
Adipose tissue consists of various types of cells, including
fibroblasts, vascular cells, and macrophages. It is becoming
evident that intercellular communication inside adipose tissue
is crucial for the maintenance of normal metabolism. Different
subsets of macrophages have been shown to contribute to adi-
pose tissue inflammation (Gordon, 2007; Lumeng et al., 2008;
Zeyda and Stulnig, 2007). Under normal conditions, adipocytes
store lipids and regulate metabolic homeostasis, while resident
tissue macrophages with the M2 phenotype release anti-inflam-
matory cytokines to promote tissue repair and the resolution of
inflammation. Under obese conditions, excessive intake of nutri-
ents causes adipose tissue remodeling that leads to a shift of the
cytokine profile, creating a tissue milieu responsible for trans-
forming the pool of adipose tissue macrophages from the M2
(alternatively activated) phenotype to the M1 (classically acti-
vated) phenotype. It has been suggested that M1 macrophages
produce proinflammatory cytokines, thereby promoting insulin
resistance, while M2 macrophages protect against obesity-
induced insulin resistance (Lumeng et al., 2007; Odegaard and
Chawla, 2013).Metabolism 18, 491–504, October 1, 2013 ª2013 Elsevier Inc. 491
Figure 1. Sema3E-plexinD1 Is Upregulated in Adipose Tissue of Obese Mice
(A) FACS analysis of CD45+ and F4/80+ cells in adipose tissue of mice fed normal chow (NC) or a high-fat/high-sucrose (HFHS) diet (n = 4–6). Representative
results are shown in the right panels.
(B) Real-time PCR detecting expression of Emr1, Tnf (TNF-a), and Ccl2 (MCP-1) in adipose tissue of mice given NC or an HFHS diet (n = 5).
(C) ELISA for TNF-a and Ccl2 (MCP-1) protein in adipose tissue (n = 7–9).
(D) Real-time PCR assessing expression of Sema3e and plexinD1 (Plxnd1) in adipose tissue (n = 6).
(legend continued on next page)
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Semaphorin in Adipose TissueSemaphorins and their receptors (plexins) were initially char-
acterized according to their role in repulsive axon guidance
(Luo et al., 1993; Ohta et al., 1995; Song et al., 1998; Tamag-
none et al., 1999) but are now known to be crucial regulators
of morphogenesis in a wide range of organ systems, including
development of the cardiovascular system, skeleton, kidneys,
and the nervous system during embryogenesis (Kruger et al.,
2005; Pera¨la¨ et al., 2012; Roth et al., 2009; Tran et al., 2007).
Among eight known classes of semaphorins, vertebrates have
five (classes 3–7) (Zhou et al., 2008). Class 3 semaphorins
(Sema3s) are secreted molecules, and there are seven family
members (Sema3A–3G). Sema3s have been shown to con-
tribute to neuronal and cardiovascular morphogenesis, but
also to pathological conditions of the nervous system and to
cancer through their effects on cell growth, survival, migration,
and proliferation (Kruger et al., 2005; Pera¨la¨ et al., 2012; Roth
et al., 2009; Tran et al., 2007; Zhou et al., 2008). Although
Sema3s were previously identified as repulsor molecules,
recent studies have demonstrated that they are bifunctional
and can exert repulsive or attractive effects depending on the
biological context (Bagnard et al., 1998; Chauvet et al., 2007;
Falk et al., 2005; Gay et al., 2011). Sema3s do not usually
interact directly with the plexin receptor but instead bind to
neuropilin-1 (Nrp1) or Nrp2, leading to assembly and activation
of the Nrp-plexinA (or Nrp-plexinD1) holoreceptor complex
(Pera¨la¨ et al., 2012). An exception is Sema3E, which binds to
its specific receptor plexinD1 with a high affinity (Gu et al.,
2005). There is evidence that the Sema3E-plexinD1 axis also
plays a critical role in the pathogenesis of cardiovascular dis-
ease and tumor growth, as well as being involved in morphogen-
esis (Casazza et al., 2010; Fukushima et al., 2011; Gay et al.,
2011; Gu et al., 2005; Moriya et al., 2010; Roodink et al.,
2008). Our previous study showed that Sema3E is upregulated
in the diabetic state and inhibits neoangiogenesis in ischemic
tissues (Moriya et al., 2010). The semaphorins and plexins
have also been reported to regulate the immune system (Pera¨la¨
et al., 2012; Roth et al., 2009; Suzuki et al., 2008). For example,
plexinA1 enhances dendritic cell stimulation and transmigration.
Aggregation of monocytes is induced by treatment with viral
semaphorin (SemaVA), and SemaVA (secreted by cells infected
with vaccinia virus) has been shown to upregulate the expres-
sion of proinflammatory cytokines and adhesion molecules in
monocytes (Comeau et al., 1998).
Given the important role of semaphorins and plexins in inflam-
mation, we hypothesized that semaphorins (particularly the
secreted Sema3s) might contribute to adipose tissue inflamma-
tion associated with obesity, thereby promoting the develop-
ment of insulin resistance and diabetes. Here we show that
Sema3E and plexinD1 are crucially involved in the inflammatory
response of adipose tissue to a high-calorie diet that leads to
various metabolic abnormalities.(E and F) Immunofluorescent staining for Sema3E (E) and plexinD1 (F) (red, indica
and Sema3e-deficient mice (Sema3EKO) fed the HFHS diet. Nuclei and plasma
lectin (green). Scale bar, 50 mm.
(G) FACS analysis of CD45+ plexinD1+ and F4/80+ plexinD1+ cells in adipose tiss
(H) Plasma level of Sema3E in mice was examined by ELISA (n = 6).
(I) Plasma level of Sema3E in diabetic patients (DM, n = 25) and control subjects
Data were analyzed by Student’s t test. *p < 0.05, **p < 0.01. All values represen
CellRESULTS
The Sema3E-plexinD1 Axis Is Upregulated in Obese
Adipose Tissue
To investigate the role of semaphorins and plexins in adipose tis-
sue inflammation, we generated a diet-induced obesity (DIO)
model by feeding mice a high-fat/high-sucrose (HFHS) diet.
Compared with mice fed a normal diet, there was increased infil-
tration of mononuclear cells into visceral fat (Figure 1A and Fig-
ure S1A available online). Most infiltrating hematopoietic cells
(CD45) were identified as macrophages by FACS analysis for
F4/80 and quantitative PCR detection of a macrophage marker
(Egf-like module containing, mucin-like, hormone receptor-like
1 [EMR1]) (Figures 1A and 1B and Figure S1B). In addition, pro-
duction of proinflammatory cytokines such as Tnf (TNF-a) and
Ccl2 (MCP-1) was significantly increased in mice receiving the
HFHS diet (Figures 1B and 1C). The results of the insulin
tolerance test (ITT) and glucose tolerance test (GTT) indicated
marked impairment of glucose homeostasis in this model
(Figure S1C).
Next, we examined the expression of Sema3s in various tis-
sues of the DIO mice and found that Sema3E expression was
the most strikingly upregulated among the Sema3s in obese
adipose tissue, along with increased expression of plexinD1
(Figure 1D and Figures S1D–S1F). Immunostaining of adipose
tissue showed that Sema3E was mainly expressed in the cyto-
plasm of adipocytes (Figure 1E), whereas expression of plexinD1
was increased in both infiltrating cells and adipocytes (Figure 1F).
FACS analysis demonstrated that most of the CD45+ cells and
F4/80+ cells infiltrating obese adipose tissue were positive for
plexinD1 (Figure 1G). Consistent with these results, expression
of Sema3Ewas predominant in the adipocyte-rich fraction, while
plexinD1 expression was observed in both the stromal vascular
fraction and the adipocyte-rich fraction (Figure S1G). These
changes were associated with an increase of the plasma
Sema3E level (Figure 1H), suggesting a potential interaction
between Sema3E secretion by adipose tissue and plexinD1
expression by macrophages. Moreover, we observed that the
plasma level of Sema3E was elevated in patients with diabetes
(Figure 1I), suggesting a potential role of the Sema3E-plexinD1
axis in human metabolic disease.
Role of the Sema3E-plexinD1 Axis in Adipose Tissue
Inflammation
To further investigate the role of the Sema3E-plexinD1 axis in
obesity, we examined the effects of soluble form of plexinD1
(plexinD1-Fc), which binds to Sema3E and inhibits its activity,
on adipose tissue inflammation. PlexinD1-Fc was generated
with a plasmid vector expressing the extracellular domain of
mouse PlexinD1 (Met1-Gly1266) fused to the Fc domain of
human IgG under the control of the CAG promoter. Theted by white arrows) in adipose tissue of wild-type mice fed NC or a HFHS diet
membranes were stained with Hoechst dye (blue) and wheat germ agglutinin
ue of mice fed the HFHS diet.
(Cont, n = 10) was examined by ELISA. ND indicates not detected by ELISA.
t the mean ± SEM. See also Figure S1.
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Figure 2. Inhibition of the Sema3E-plexinD1 Axis Attenuates Adipose Tissue Inflammation
(A) FACS analysis of CD45+ and F4/80+ cells in adipose tissue of mice fed a high-fat/high-sucrose (HFHS) diet and treated with an empty vector (Mock) or a vector
encoding plexinD1-Fc (Fc) (n = 4–5).
(legend continued on next page)
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Semaphorin in Adipose TissuePlexinD1-Fc expression vector (100 mg) was injected into the
bilateral quadriceps femoris muscles once a week from 4 to
12 weeks of age in mice fed the HFHS diet. The plasma level
of plexinD1-Fc was significantly higher in mice treated with the
expression vector encoding plexinD1-Fc compared with that in
mice receiving the empty vector (Mock) (Figure S2A). Injection
of the plexinD1-Fc vector reduced the infiltration of hematopoi-
etic cells and macrophages into adipose tissue (Figure 2A and
Figure S2B) and decreased the expression of Emr1, plexinD1,
and proinflammatory cytokines (Figure 2B and Figures S2C
and S2D), although there were no changes of body weight,
food intake, oxygen consumption, visceral fat mass, adipose tis-
sue vascularity, or Sema3E expression (Figure 2C and Figures
S2E–S2J). Consequently, treatment with the plexinD1-Fc vector
significantly improved insulin resistance and glucose intolerance
in mice fed the HFHS diet (Figure 2D).
We next examined the effect of genetic disruption of Sema3e
on adipose tissue inflammation in homozygous Sema3e
knockout (KO) mice. There were no changes of body weight,
food intake, or visceral fat mass (data not shown). However,
FACS analysis showed thatSema3e deficiency led to a decrease
of macrophages in adipose tissue (Figure 2E). Dietary-induced
upregulation of the expression of Emr1, plexinD1, and proinflam-
matory cytokines was also less marked in homozygous Sema3e
KO mice (Figure 2F and Figures S2K and S2L), while adipose
tissue vascularity was unchanged (Figure S2M). Homozygous
Sema3e KO mice fed the HFHS diet showed improvement of
insulin sensitivity and glucose tolerance compared with their
littermate controls (Cont) (Figure 2G), suggesting that the
Sema3E-plexinD1 axis had an adverse influence on adipose tis-
sue inflammation and glucose metabolism in our DIO model.
Sema3E Overexpression Causes Adipose Tissue
Inflammation
To determine whether Sema3E overexpression causes adipose
tissue inflammation, we generated adipocyte-specific Sema3e
transgenic mice using a construct containing full-length Sema3e
cDNA driven by the Fabp4 promoter and fed them a normal diet.
Thesemice showed a significant increase of Sema3e expression
in adipose tissue and had significantly higher plasma Sema3E
levels compared with their littermate controls (Cont) (Figures
3A–3D). There were no changes of body weight, food intake, or
visceral fat mass (Figure S3A). However, overexpression of
Sema3E led to an increase of infiltrating hematopoietic cells
and macrophages in the adipose tissue of mice on a normal
diet (Figure 3E), as well as upregulating the expression of
Emr1, Itgam (CD11b), Itgax (CD11c), Plxnd1, and proinflamma-
tory cytokines in visceral fat (Figure 3F and Figure S3B). The re-
sults of the ITT and GTT indicated that Sema3E transgenic mice(B) Real-time PCR detecting expression of Emr1, Plxnd1, Tnf, and Ccl2 in the ad
(C) Real-time PCR detecting expression of Sema3e in adipose tissue (left) and p
(D) Insulin tolerance test (ITT) and glucose tolerance test (GTT) (n = 8–12).
(E) FACS analysis of CD45+ and F4/80+ cells in adipose tissue of littermate contr
diet (n = 6).
(F) Real-time PCR assessing expression of Emr1, Plxnd1, Tnf, and Ccl2 (MCP1)
(G) ITT and GTT (n = 6–8).
Data were analyzed by Student’s t test (A and E) or one-way ANOVA (B–D, F, andG
##p < 0.01 versus PlexinD1-Fc or Sema3EKO (D and G). All values represent the
Celldeveloped both insulin resistance and glucose intolerance
(Figure 3G and Figure S3C). Moreover, insulin-induced phos-
phorylation of Akt was impaired in various tissues, such as the
liver, skeletal muscle, and visceral fat, of Sema3E transgenic
mice compared with their littermate controls (Figure S3D). Treat-
ment of Sema3E transgenic mice with a TNF-a neutralizing anti-
body significantly ameliorated these metabolic abnormalities
(Figure 3G). Sema3E transgenic mice showed a slight, but signif-
icant, increase of inflammatory markers in the liver (Figure S3E),
suggesting that hepatic inflammation may have a role in the
development of insulin resistance in these animals.
Since Fabp4 can be expressed by macrophages, we next
examined the expression of Sema3E in the adipocyte-rich and
vascular stromal fractions of visceral fat tissues from Sema3E
transgenic mice and their littermate controls. We detected
marked upregulation of Sema3E expression in the adipocyte-
rich fraction (Figure S3F). Although basal Sema3E expression
was much lower in the vascular stromal fraction, it showed a sig-
nificant increase in Sema3E transgenic mice (Figure S3F). We
therefore examined glucose metabolism in Sema3E transgenic
mice after transplantation of bone marrow cells derived from
wild-typemice, and found that both insulin tolerance and glucose
tolerance were unaffected by transplantation (Figure 3H).
Sema3EActs as aChemoattractant forMacrophages via
plexinD1/Nrp1/VEGFR2
Inflammatory cells, including macrophages, express the CCL2
receptor (C-C motif chemokine receptor-2, CCR2) and are
attracted to infected, damaged, or inflamed tissues in response
to secretion of CCL2. Because our results suggested a potential
interaction between the Sema3s secreted by adipose tissue and
plexinD1 expressed by macrophages, we performed an in vitro
migration assay to investigate whether or not Sema3s acted as
chemoattractants. Addition of each Sema3 protein to the lower
chamber significantly increased the number of macrophages
migrating from the upper chamber (Figure 4A and Figure S4A).
Sema3E (1 nM) was the most potent of the Sema3s tested and
showed similar activity to that of Ccl2 (36.2 nM) for inducing
the migration of macrophages (Figure 4A and Figure S4A). We
next performed a migration assay using conditioned media
obtained from the visceral fat tissues of wild-type or Sema3E
KO mice. Conditioned medium from the visceral fat tissue of
wild-type mice fed the HFHS diet contained a higher concentra-
tion of Sema3E and therefore promoted macrophage migration
compared with medium from mice fed a normal diet (Figure 4B
and Figure S4B). This increase of macrophage migration was
significantly reversed by conditioned medium obtained from
the visceral fat tissue of Sema3E KO mice receiving the HFHS
diet (Figure 4B).ipose tissue of mice fed normal chow (NC) or a HFHS diet (n = 5–9).
lasma Sema3E level (right) (n = 5–6).
ols (Cont) and Sema3e homozygous knockout (Sema3E KO) mice fed a HFHS
in adipose tissue of mice fed NC or a HFHS diet (n = 6–10).
). *p < 0.05, **p < 0.01 (A–C, E, and F). *p < 0.05, **p < 0.01 versus NC; #p < 0.05,
mean ± SEM. See also Figure S2.
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Figure 3. Overexpression of Sema3E Induces Adipose Tissue Inflammation
(A) Immunofluorescent staining for Sema3E (red) in adipose tissue from mice overexpressing Sema3E (Sema3E Tgm) and littermate controls (Cont). Nuclei and
plasma membranes were stained with Hoechst dye (blue) and wheat germ agglutinin lectin (green). Scale bar, 50 mm.
(legend continued on next page)
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Figure 4. Sema3E Is a Chemoattractant for
Macrophages
(A) In vitro migration assay with PBS, Sema3E
(1 nM) or MCP-1 (500 ng ml1 = 36.2 nM) (n = 5–7).
(B) In vitro migration assay with conditioned
medium from the visceral fat tissue of littermate
controls (Cont) or Sema3E knockout (Sema3E KO)
mice fed normal chow (NC) or an HFHS diet.
(C) Western blot analysis of plexinD1 expression in
RAW264.7 cells infected with a lentiviral vector
expressing shRNA targeting Plxnd1 (sh-Plxnd1) or
a control vector (sh-Cont).
(D) In vitro migration assay using RAW264.7 cells
infected with sh-Plxnd1 or sh-Cont (n = 5–7).
(E) In vitromigration assay using RAW264.7 cells in
the presence of Ki8751 (a VEGFR2 inhibitor,
0.1 mM), Ly294002 (a PI3K inhibitor, 5 mM), Wort-
mannin (a PI3K inhibitor, 50 nM), or GSK690693
(an Akt inhibitor, 20 mM).
Data were analyzed by one-way ANOVA. **p <
0.01. All values represent the mean ± SEM. See
also Figure S4.
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Semaphorin in Adipose TissueTo determine whether plexinD1 mediated the induction of
macrophage migration by Sema3E, we disrupted plexinD1
expression in macrophages by introducing a short hairpin RNA
(shRNA) for Plxnd1 (sh-Plxnd1) via a lentiviral vector, while other
macrophages were infected with a control vector (sh-Cont).
Infection of macrophages with the sh-Plxnd1 vector markedly
reduced plexinD1 expression (Figure 4C) and also significantly
inhibited Sema3E-induced macrophage migration (Figure 4D).
In contrast, Ccl2-inducedmigration was not affected by infection
with sh-Plxnd1 (Figure 4D). Sema3E is known to function as a re-
pellent, but it was recently demonstrated that Sema3E can also
induce axonal attraction via a plexinD1/Nrp1/vascular endothe-
lial cell growth factor receptor 2 (VEGFR2) complex that acti-
vates the PI3K/Akt pathway (Bellon et al., 2010; Chauvet et al.,
2007). Consistent with these reports, we found that disruption
of Nrp1 markedly inhibited Sema3E-induced macrophage
migration (Figure S4C). Inhibition of the VEGFR2/PI3K/Akt
pathway also significantly attenuated macrophage migration
(Figure 4E), suggesting that Sema3E acts as a chemoattractant(B and C) Expression of Sema3e in adipose tissue was examined by western blot analysis (B) and real-time
(D) Plasma level of Sema3E was examined by ELISA (n = 7).
(E) FACS analysis of CD45+ and F4/80+ cells in adipose tissue (n = 5–6).
(F) Real-time PCR assessing expression of Emr1, Plxnd1, Tnf, and Ccl2 in adipose tissue (n = 5–7).
(G) Insulin tolerance test (ITT) and glucose tolerance test (GTT) (n = 4–6) in Sema3E transgenic mice (Sema3E T
a neutralizing antibody for TNF-a (NAb) or control IgG (IgG).
(H) ITT and GTT (n = 4–6) in Sema3E transgenic mice (Sema3E Tgm) and their littermate controls (Cont) with
type mice (BMT).
Data were analyzed by Student’s t test (C–F) or one-way ANOVA (G and H). *p < 0.05, **p < 0.01 (C–F). *p < 0.
##p < 0.01 versus Sema3E Tgm + NAb or Cont + BMT (G and H). All values represent the mean ± SEM. See
Cell Metabolism 18, 491–504for macrophages via a plexinD1/Nrp1/
VEGFR2-dependent mechanism.
In addition to acting as a chemoattrac-
tant, Sema3E activated p38MAPK and
upregulated the expression of proinflam-
matory cytokines in macrophages (Fig-
ures S4D and S4E). Moreover, Sema3E
activated p38MAPK, upregulated theexpression of proinflammatory cytokines, and inhibited insulin-
induced phosphorylation of Akt in adipocytes (Figures S4F–
S4H). These findings indicated that Sema3E induces adipose
tissue inflammation by recruiting macrophages and by directly
influencing the intracellular signaling pathways of both adipo-
cytes and infiltrating cells.
Disruption of plexinD1 in Bone Marrow Cells Inhibits
Macrophage Infiltration into Visceral Fat Tissue
Next, we examined the effect of deleting plexinD1 from bone
marrow cells on the infiltration of macrophages into the visceral
fat of mice fed the HFHS diet. Bone marrow cell suspensions
were isolated from 8-week-old wild-type male mice. Then cell
suspensions were cultured in DMEM with 10% FBS containing
sh-Plxnd1 lentivirus or a control virus (sh-Cont) for 48 hr. Non-
purified cultured bone marrow cells were injected into irradiated
wild-type recipient mice via the tail vein. Subsequently, we fed
recipient mice the HFHS diet or a normal diet for 8 weeks. Trans-
plantation of bone marrow cells infected with the sh-Plxnd1PCR (C) (n = 7).
gm) and their littermate controls (Cont) treatedwith
or without bone marrow transplantation from wild-
05, **p < 0.01 versus Cont + IgG or Cont; #p < 0.05,
also Figure S3.
, October 1, 2013 ª2013 Elsevier Inc. 497
Figure 5. Deletion of plexinD1 from
Bone Marrow Cells Inhibits Macrophage
Infiltration
(A) Western blot analysis of plexinD1 expression in
bone marrow cells infected with a lentiviral vector
expressing shRNA targeting Plxnd1 (sh-Plxnd1) or
a control vector (sh-Cont).
(B) FACS analysis of CD45+ and F4/80+ cells in
adipose tissue of mice after transplantation of
bone marrow cells infected with sh-Plxnd1 or sh-
Cont (n = 6).
(C) Real-time PCR assessing expression of Emr1,
Tnf, and Ccl2 in adipose tissue (n = 4–7).
(D) ITT and glucose tolerance test (GTT) (n = 6–8).
(E) Real-time PCR assessing expression of
Sema3e and Plxnd1 in adipose tissue (n = 4–6).
Data were analyzed by Student’s t test (B) or one-
way ANOVA (C–E). *p < 0.05, **p < 0.01 (B, C,
and E). *p < 0.05, **p < 0.01 versus sh-Cont + NC;
#p < 0.05, ##p < 0.01 versus sh-Plxnd1 + HFHS (D).
All values represent the mean ± SEM. See also
Figure S5.
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Semaphorin in Adipose Tissuevector led to a significant decrease of plexinD1 expression by
myeloid cells with no evidence of nonphysiological inflammation
(Figure 5A, Figures S5A–S5C; and data not shown). Exposure to
the HFHS diet increased macrophage infiltration and proinflam-
matory cytokine expression in the adipose tissue of mice trans-
planted with control bone marrow cells, while these changes
were significantly ameliorated in mice transplanted with bone
marrow cells lacking plexinD1 (Figures 5B and 5C). Accordingly,
insulin resistance and glucose intolerance related to the HFHS
diet were significantly improved by deletion of plexinD1 from
bone marrow cells (Figure 5D). There were no significant differ-
ences with respect to peripheral white blood cell counts and
metabolic parameters such as body weight, food intake, and
fat weight between the sh-Cont and sh-Plxnd1 groups (Figures
S5C and S5D). PlexinD1 expression in the adipose tissue of
recipient mice was significantly suppressed after transplantation
with bone marrow cells lacking plexinD1, whereas Sema3E
expression was unaltered (Figure 5E). These results suggested
that the HFHS diet promotes recruitment of macrophages into
adipose tissue via plexinD1-mediated signaling.
Disruption of p53 Inhibits Adipose Tissue Inflammation
by Downregulating Sema3E Expression
We next sought to elucidate the mechanism that regulates
Sema3E expression. It has been demonstrated that excessive498 Cell Metabolism 18, 491–504, October 1, 2013 ª2013 Elsevier Inc.calorie intake leads to the accumulation
of ROS and DNA damage that upregu-
lates p53 in adipose tissue (Minamino
et al., 2009; Tchkonia et al., 2010). Upre-
gulation of p53 induces inflammation of
adipose tissue and the development of
systemic insulin resistance (Minamino
et al., 2009). There is also evidence that
Sema3s are upregulated by activation of
p53 in cancer cells and that this contrib-
utes to p53-mediated tumor suppression
(Futamura et al., 2007; Ochi et al., 2002).We observed that expression of both p53 and its target gene,
cyclin-dependent kinase inhibitor 1A (Cdkn1a), was markedly
upregulated in adipose tissue when mice were given the HFHS
diet (Figures S6A and S6B), as previously reported (Minamino
et al., 2009). To test whether upregulation of p53 influenced
Sema3E expression, we generated adipocyte-specific p53
knockout (adipo-p53KO) mice and fed these animals the HFHS
diet. We found that upregulation of p53 and Cdkn1a expression
by the HFHS diet was significantly less marked in the visceral
fat of adipo-p53KO mice (Figures 6A and 6B). Likewise, the
increase of Sema3e expression induced in adipose tissue by
the HFHS diet was significantly less prominent in adipo-p53KO
mice (Figures 6C and 6D). Elevation of the plasma Sema3E
level in the DIO model was also reduced by disruption of
adipose tissue p53 expression (Figure 6E). Consequently,
disruption of p53 in adipose tissue inhibited HFHS diet-induced
upregulation ofEmr1,Plxnd1, and proinflammatory cytokines, as
well as improving insulin resistance and glucose intolerance in
this DIO model (Figures 6F and 6G), suggesting that recruitment
of plexinD1-positive macrophages by Sema3E mediates p53-
induced adipose tissue inflammation in animals with dietary
obesity.
To further investigate the relationship between p53 and
the Sema3E-plexinD1 axis, we treated adipo-p53 KO mice
with plexinD1-Fc while they were receiving a HFHS diet and
Figure 6. Disruption of p53 Inhibits Adipose
Tissue Inflammation by Downregulating
Sema3E Expression
(A) Western blot analysis of p53 expression in
adipose tissue from littermate controls (Cont) and
adipocyte-specific p53-deficient mice (Adipo-p53
KO) fed a normal chow (NC) or a high-fat/high-
sucrose (HFHS) diet.
(B) Real-time PCR assessing expression of
Cdkn1a (n = 4–6).
(C) Immunofluorescent staining of adipose tissue
for Sema3E (red). Nuclei and plasma membranes
were stained with Hoechst dye (blue) and wheat
germ agglutinin lectin (green). Scale bar, 50 mm.
(D) Real-time PCR assessing expression of
Sema3e and Plxnd1 in adipose tissue (n = 5–7).
(E) Plasma level of Sema3E (n = 9–12).
(F) Real-time PCR assessing expression of Emr1,
Tnf, and Ccl2 in adipose tissue (n = 8–11).
(G) Insulin tolerance test (ITT) and glucose toler-
ance test (GTT) (n = 3).
(H) Expression of Emr1 in adipose tissue (n = 4–6).
Data were analyzed by one-way ANOVA (B, D–H).
*p < 0.05, **p < 0.01 (B, D–F). *p < 0.05, **p < 0.01
versus NC; #p < 0.05, ##p < 0.01 versus Cont
HFHS (G). All values represent the mean ± SEM.
See also Figure S6.
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metabolism. We found that expression of both Sema3e and
Cdkn1a was downregulated by disruption of adipose tissue
p53 irrespective of plexinD1 treatment (Figure S6C). Compared
with mock-treated animals, treatment of littermate controls
with plexinD1-Fc significantly inhibited adipose tissue inflamma-
tion, as demonstrated by decreased infiltration of macrophages
and decreased expression of proinflammatory cytokines, but no
further improvement of inflammation was observed in adipo-p53
KOmice receiving this treatment (Figure 6H and Figures S6D and
S6E). Likewise, this treatment improved HFHS diet-induced
metabolic abnormalities in littermate controls, but no additional
benefit was found in adipo-p53 KO mice (Figure S6F). These re-
sults further suggested an essential role of the Sema3E-plexinD1
axis in p53-induced adipose tissue inflammation.
Activation of p53ProvokesAdipose Tissue Inflammation
via the Sema3E-plexinD1 Axis
To test the effect of p53 activation on Sema3E-regulated glucose
metabolism, we administered quinacrine (a p53 activator) into
the adipose tissue of mice fed a normal diet and examined the
effect on tissue inflammation. We found that quinacrine upregu-
lated the expression of both Sema3e and Cdkn1a in adipose tis-
sue (Figure 7A and Figure S7A), with the plasma Sema3E level
also being elevated (Figure 7B and Figure S7B). Upregulation
of Sema3E led to increased expression of macrophage markers
and proinflammatory cytokines in adipose tissue (Figure 7C and
Figure S7C), as well as impairment of glucose metabolism (Fig-
ure S7D). These changes due to quinacrine treatment were abol-
ished in adipose-p53 KO mice (Figures 7A–7C and Figure S7D),
suggesting that quinacrine induced adipose tissue inflammation
in a p53-dependent manner. However, we could not exclude the
possibility that quinacrine treatment activated p53-dependent
inflammation in various tissues, leading to the development of
metabolic abnormalities. We also observed that overexpression
of p53 led to upregulation of Sema3e expression, but not Plxnd1
expression, in preadipocytes (Figures 7D and 7E). This upregula-
tion was associated with increased expression of known p53
target genes (Figure S7E). The ChIP assay demonstrated that
p53 binds to one of the putative regulatory elements at the
SEMA3E gene locus (Figure 7F), and this element was found to
be conserved between human and mouse (data not shown).
Although treatment with plexinD1-Fc did not alter the expression
of Sema3e or Cdkn1a in adipose tissue (Figure 7G), it signifi-
cantly downregulated the expression of macrophage markersFigure 7. p53 Regulates the Expression of Sema3E
(A) Real-time PCR assessing expression ofCdkn1a andSema3e in adipose tissue
p53 KO) treated with PBS or quinacrine (n = 4–5).
(B) Plasma level of Sema3E (n = 4–5).
(C) Real-time PCR assessing expression of Emr1, Plxnd1, Tnf, and Ccl2 in adipo
(D) Western blot analysis of p53 expression in preadipocytes infected with an ad
(E) Real-time PCR assessing expression of Sema3e and Plxnd1 in preadipocytes
(F) ChIP assay assessing the direct association of p53 with the SEMA3E gene (n
(G) Real-time PCR assessing expression of Cdkn1a and Sema3e in adipose tissu
empty vector (Mock) or a vector encoding PlexinD1-Fc (Fc) (n = 5–6).
(H) Real-time PCR assessing expression of Emr1, Plxnd1, Tnf, and Ccl2 in adipo
(I) Insulin tolerance test (ITT) and glucose tolerance test (GTT) (n = 5).
Data were analyzed by Student’s t test (E and F) and one-way ANOVA (A–C andG–
#p < 0.05, ##p < 0.01 versus Quinacrine + Fc (I). All values represent the mean ±
Celland proinflammatory cytokines in visceral fat and also improved
metabolic abnormalities in quinacrine-treated mice (Figures 7H
and 7I). Treatment with a TNF-a neutralizing antibody signifi-
cantly improved various metabolic abnormalities in quinacrine-
treated mice (Figure S7F). These results suggest that Sema3E
plays a crucial role in p53-induced adipose tissue inflammation
associated with dietary obesity.
DISCUSSION
In the present study, we demonstrated that the Sema3E-
plexinD1 axis is crucial for the development of adipose tissue
inflammation that leads to systemic insulin resistance and
diabetes mellitus. Sema3E recruits plexinD1-positive macro-
phages. Activation of adipose tissue p53 positively regulates
Sema3E-induced infiltration of macrophages into visceral fat,
leading to adipose tissue inflammation and metabolic abnormal-
ities associated with dietary obesity. However, we could not
exclude the possibility that Sema3E interferes with the efflux of
macrophages from adipose tissue, since an increase of adipose
tissue macrophages is the net result of an imbalance between
influx and efflux.
In the obese state, adipose tissue is poorly oxygenated, and
the hypoxic environment has been postulated to promote an in-
flammatory response during adipose tissue remodeling (Sun
et al., 2011; Ye et al., 2007). We also found that the expression
of endothelial markers was decreased in the adipose tissue of
obesemice. Although previous studies have shown that Sema3E
inhibits angiogenesis in ischemic tissues and cancer tissues
(Fukushima et al., 2011; Moriya et al., 2010; Roodink et al.,
2008; Sakurai et al., 2010), the vascularity of adipose tissue
was not altered by disruption or upregulation of Sema3E in our
model, suggesting that the antiangiogenic activity of Sema3E
only has a minor influence on adipose tissue inflammation.
We demonstrated that Sema3E acts as a chemoattractant
rather than a repellent for macrophages via a plexinD1/Nrp1/
VEGFR2-dependent mechanism. Consistent with our results, a
bifunctional role of Sema3E-plexinD1 has already been shown
in the vascular system and the nervous system (Chauvet et al.,
2007; Fukuda et al., 2013; Gay et al., 2011). Sema3E promoted
the infiltration of proinflammatory macrophages, with this
increase being significantly suppressed by treatment with
PlexinD1-Fc or by disruption of Sema3E expression, although
we could not obtain consistent results regarding the effect of
Sema3E on the M2 phenotype (Figures 2B and 2F and Figuresfrom littermate controls (Cont) or adipocyte-specific p53-deficient mice (Adipo-
se tissue (n = 4–6).
enoviral vector encoding p53 (Adeno-p53) or LacZ (Cont).
prepared in Figure 7D (n = 3–4).
= 4).
e from mice treated with PBS or quinacrine, followed by transduction with an
se tissue (n = 5).
I). *p < 0.05, **p < 0.01 (A–C and E–H). *p < 0.05, **p < 0.01 versus PBS +Mock;
SEM. See also Figure S7.
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p38MAPK and upregulated the expression of proinflammatory
cytokines by macrophages, suggesting that it induces adipose
tissue inflammation not only by recruiting macrophages, but
also via a direct influence on the intracellular signaling pathways
of infiltrating cells. Among the various Sema3s, Sema3E showed
the most marked increase in the adipose tissue of obese ani-
mals, and the migration assay revealed that Sema3E was the
most potent recruiter of macrophages. These results indicate
that Sema3E is the key regulator of adipose tissue inflammation
related to p53 activation.
The p53 tumor suppressor pathway coordinates DNA repair,
apoptosis, and senescence to preserve genomic stability and
prevent tumorigenesis. Its activity is regulated by a wide variety
of stress signals, including DNA damage, oxidative stress, and
oncogene activation (Meek, 2009). Recently, the contribution
of p53 tomany undesirable aspects of aging and age-associated
diseases has been reported (Vousden and Lane, 2007). It has
been shown that aging is associated with an increase of p53-
mediated transcriptional activity (Edwards et al., 2007) and that
a low level of constitutive p53 activation leads to premature
aging in mice (Maier et al., 2004; Tyner et al., 2002). Activation
of p53 has also been observed in aged vessels and failing hearts,
and has been suggested to have a role in atherosclerosis and
heart failure (Minamino and Komuro, 2007, 2008; Sano et al.,
2007). Recent studies have also identified a role of p53 in deter-
mining the response of cells to nutrient stress and in regulating
metabolism (Minamino et al., 2009; Tchkonia et al., 2010; Vous-
den and Ryan, 2009). Production of most adipokines is upregu-
lated in the obese state, and these proinflammatory proteins
typically promote obesity-linked metabolic diseases (Ouchi
et al., 2011). We previously showed that excessive calorie intake
led to p53-induced inflammation in adipose tissue, while p53
deficiency downregulated the expression of these proinflamma-
tory cytokines in obese adipose tissue (Minamino et al., 2009).
These results suggested that activation of p53 in adipose tissue
plays a major role in the development of adipose tissue inflam-
mation in obese animals. In the present study, we found that
the Sema3E-plexinD1 axis is critical for the induction of inflam-
mation in adipose tissue by p53 and that inhibition of this axis
improves metabolic abnormalities related to dietary-induced
obesity. Since disruption of p53 itself has the potential to pro-
mote cancer, inhibition of the Sema3E-plexinD1 axis could be
a potential therapeutic target for improvement of glucose meta-
bolism in patients with dietary obesity.
EXPERIMENTAL PROCEDURES
Animal Models
All animal study protocols were approved by the Chiba University review
board. C57BL/6 mice were purchased from the SLC Japan (Shizuoka, Japan).
Mice were fed a HFHS diet or a normal chow from 4 to 12 weeks of age before
metabolic analyses were performed. Mice that expressed Cre recombinase in
adipocytes (Fabp4-Cre) were purchased from Jackson Laboratories. We then
crossed Fabp4-Cre mice (with a C57BL/6 background) with mice that carried
floxed Trp53 alleles with a C57BL/6 background to generate adipocyte-
specific p53 KO mice. The genotype of littermate controls was Fabp4-Cre
Trp53flox/flox. The generation and genotyping of Sema3e-deficient mice (on a
C57/BL6 background) have been described previously (Gu et al., 2005). We
generated adipocyte-specific Sema3e transgenic mice using a construct con-
taining full-length Sema3e cDNA driven by the Fabp4 promoter. We obtained502 Cell Metabolism 18, 491–504, October 1, 2013 ª2013 Elsevier In12 strains of founders (on a C57/BL6 background) and chose 2 strains for
further analysis based on the level of Sema3e expression in adipose tissue.
We confirmed that these 2 strains of mice had similar phenotypes. PlexinD1-
Fc was generated with a plasmid vector expressing the extracellular domain
ofmouse PlexinD1 (Met1-Gly1266) fused to the Fc domain of human IgG under
the control of the CAG promoter. The PlexinD1-Fc expression vector (100 mg)
was injected into the bilateral quadriceps femoris muscles once a week from
4 to 12 weeks of age in mice with DIO, or from 10 to 11 weeks of age in
quinacrine-treated mice.
Histological Analysis
Epidydimal fat samples were harvested and fixed in 10% formalin overnight.
The samples were embedded in paraffin and sectioned (Narabyouri Research
Co., Ltd.). The sections were subjected to immunohistochemistry or HE
staining. The antibodies used are anti-Sema3E antibody (Abcam), plexinD1
(Abcam), anti-F4/80 antibody (Serotec), goat Cy3-conjugated secondary anti-
body (Jackson Immunoresearch), andWGA lectin (Sigma Aldrich). The stained
sections were photographed with a Biorevo (Keyence Co.).
Laboratory Tests
Experiments were done in all animal models at 12 weeks of age unless
otherwise mentioned. For the intraperitoneal glucose tolerance test (IGTT),
mice were starved for 6 hr and were given glucose intraperitoneally at a
dose of 2 g kg1 (body weight) in the early afternoon. For the ITT, mice
were given human insulin intraperitoneally (1 U kg1 body weight) at
1:00 p.m. without starvation. Tail vein blood was collected at 0, 15, 30, 60,
and 120 min after administration, and blood glucose levels were measured
with a glucose analyzer (Roche Diagnostics). We measured the levels of
Sema3E, tumor necrosis factor (TNF-a), C-C motif chemokine 2 (MCP-1),
and insulin by using ELISA-based immunoassay kits (Sema3E, Uscn Life
Science Inc.; TNF-a and MCP-1, R&D Systems; insulin, Morinaga Institute
of Biological Science Inc.) according to the manufacturer’s instruction.
Plasma PlexinD1-Fc level was evaluated by sandwich ELISA protocol with
anti-plexinD1 antibody (Santa Cruz) and HRP-conjugated anti-V5-tag anti-
body (Gen Script).
Generation of Lentivirus-Mediated Short Hairpin RNA and
Adenoviral Stock
We used the MISSION lentiviral packaging system (Sigma Aldrich) and gener-
ated a lentiviral vector expressing shRNA targeting Plxnd1 (sh-Plxnd1) or Nrp1
(sh-Nrp1) according to the manufacturer’s instruction. We used pLKO.1 as a
negative control vector. High-titer adenoviral stocks (109 pfu) were generated
with the Adeno-X Expression System (Clontech) according to the manufac-
turer’s instructions.
Bone Marrow Transplantation Model
Bone marrow cell suspensions were isolated by flushing the femurs and tibias
harvested from 8-week-old wild-type male mice unless otherwise mentioned.
Then cell suspensions (1.53 107 cells) were cultured in DMEM with 10% FBS
containing sh-Plxnd1 lentivirus or a control virus for 48 hr. Four-week-old male
mice were exposed to total body irradiation (9 mGy) before bone marrow
transplantation, and cultured bone marrow cells (1.53 107 cells) were injected
via the tail vein within 3 hr after irradiation. Two months after transplantation,
the mice were subjected to metabolic analyses. The chimeric rate was
>95% according to FACS analysis of chimeric mice transplanted with bone
marrow cells fromGFP transgenic mice. TheGFP-positive rate in bonemarrow
was 40%–50% after transplantation of bone marrow cells infected with a len-
tiviral vector expressing GFP.
Cell Culture
NIH 3T3-L1 cells were cultured in high-glucose DMEM plus 10% fetal bovine
serum (FBS). In some experiments, NIH 3T3-L1 cells were incubated with
0.5 mM 3-isobutyl-1-methylxanthine, 1 mM dexamethasone, and 5 mg ml1
insulin (Sigma Aldrich) for 48 hr to induce differentiation. HEK293 cells and
RAW264.7 cells were cultured in DMEM with 10% FBS. In some experiments,
RAW264.7 cells were infected with the sh-PlxnD1 or sh-Nrp1 lentivirus, or with
a control virus 48 hr before use. Human preadipocytes were purchased from
Sanko (Tokyo, Japan) and cultured according to the supplier’s instruction. Inc.
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coding p53 or LacZ. We used the Corning transwell system (6.5 mm diameter
inserts with an 8.0 mm pore size, Corning) to perform the cell-migration assay
according to the manufacturer’s instruction with slight modifications.
FACS Analysis
For isolation of the stromal vascular cell fraction (SVF) from adipose tissue,
epidydimal fat was excised, minced, and placed into 15 ml of DMEM contain-
ing 10% FBS, 0.03 mg ml1 LPS-depleted collagenase cocktail (Roche), and
50 U ml1 DNase I (Roche). Then incubation was done for 45 min at 37C
with gentle agitation. The tissue lysate was subsequently filtered through a
nylon mesh (250 mm) into a 50 ml tube and centrifuged at 1000 3 g, after
which the cell pellet (SVF cells) was resuspended and washed three times
with 10 ml of PBS. Next, the cells were incubated in erythrocyte lysis buffer
for 5 min at room temperature, after which erythrocyte-depleted SVF cells
were centrifuged at 500 3 g and resuspended in FACS buffer (PBS contain-
ing 5 mM EDTA and 1% FBS) for further analysis. In some experiments, bone
marrow cells were isolated from 12-week-old mice after bone marrow trans-
plantation for FACS analysis. To perform flow cytometry, SVF cells were
incubated with the following antibodies for 30 min at room temperature in
the dark: CD45 (clone 30-F11) and F4/80 (clone CI: A3-1) (BioLegend).
Then the cells were washed and passed through a nylon mesh (100 mm), after
which flow cytometry was performed using a BD-FACS Caliber (Becton
Dickinson). To assess the expression of plexinD1, SVF cells were fixed
with 4% paraformaldehyde (Wako) and permeabilized with 0.1% Triton
X-100 in PBS. Then the cells were incubated with a plexinD1 antibody
(Abcam) for 1 hr at room temperature, followed by incubation with PerCP
Cy5.5-conjugated anti-goat antibody (Santa Cruz) for 30 min at room temper-
ature in the dark. Subsequently, the samples were blocked with goat
serum and then were incubated with additional antibodies and analyzed as
described above.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) was performed with chromatin pre-
pared from HEK293 cells infected with an adenoviral vector encoding p53
(Adeno-p53) or LacZ (Cont). Sonicated chromatin was immunoprecipitated
by employing antibodies directed against p53 (DO-1) (Santa Cruz) or normal
mouse immunoglobulin G (IgG; Sigma Aldrich), and the precipitates were
collected on protein A/G Sepharose beads (GE Healthcare). Real-time PCR
targeting the putative p53 binding site near the SEMA3E promoter region
was performed with the following pair of primers: (forward) 50-CCGGCGTA
GTTGCTGAAG-30 and (reverse) 50-GGAGCAAGAGGACATTCCAA-30.
Subjects
The ethics committee of Chiba University Graduate School of Medicine re-
viewed and approved the study protocol. We enrolled patients who were
admitted to Chiba University Hospital and healthy individuals.
Statistical Analysis
Data are shown as the mean ± SEM. Differences between groups were exam-
ined by Student’s t test or one-way ANOVA followed byBonferroni’s correction
for comparison of means. For all analyses, p < 0.05 was considered statisti-
cally significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cmet.2013.09.001.
ACKNOWLEDGMENTS
We thank C.E. Henderson for providing Sema3e-deficient mice, and E. Taka-
hashi, M. Iijima, and I. Sakamoto for their technical assistance. This work was
supported by a Grant-in-Aid for Scientific Research from the Ministry of Edu-
cation, Culture, Sports, Science, and Technology (MEXT) of Japan, and by
grants from the Ono Medical Research Foundation, the Uehara Memorial
Foundation, the Daiichi-Sankyo Foundation of Life Science, the Novartis Foun-Celldation for the Promotion Science, the Japan Diabetes Foundation, the Mitsui
Life Social Welfare Foundation, the Naito Foundation, the Japanese Society
of Anti-Aging Medicine, the Life Science Foundation of Japan, the Senshin
Medical Research Foundation, the Takeda Science Foundation, theMitsubishi
Pharma Research Foundation, and the Takeda Medical Research Foundation
(to T.M.), as well as by a Grant-in-Aid for Scientific Research from the Ministry
of Education, Science, Sports, Culture, and Health, and by grants from the
UeharaMemorial Foundation, Takeda Science Foundation, Kowa Life Science
Foundation, Manpei Suzuki Diabetes Foundation, Kanae Foundation for the
Promotion of Medical Science (to I.S.), and the Japan Heart Foundation
Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant (to Y.Y.).
Received: March 20, 2013
Revised: July 10, 2013
Accepted: August 13, 2013
Published: October 1, 2013
REFERENCES
Bagnard, D., Lohrum, M., Uziel, D., Pu¨schel, A.W., and Bolz, J. (1998).
Semaphorins act as attractive and repulsive guidance signals during the devel-
opment of cortical projections. Development 125, 5043–5053.
Bellon, A., Luchino, J., Haigh, K., Rougon, G., Haigh, J., Chauvet, S., and
Mann, F. (2010). VEGFR2 (KDR/Flk1) signaling mediates axon growth in
response to semaphorin 3E in the developing brain. Neuron 66, 205–219.
Casazza, A., Finisguerra, V., Capparuccia, L., Camperi, A., Swiercz, J.M.,
Rizzolio, S., Rolny, C., Christensen, C., Bertotti, A., Sarotto, I., et al. (2010).
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and
metastatic spreading in mice. J. Clin. Invest. 120, 2684–2698.
Chauvet, S., Cohen, S., Yoshida, Y., Fekrane, L., Livet, J., Gayet, O., Segu, L.,
Buhot, M.C., Jessell, T.M., Henderson, C.E., and Mann, F. (2007). Gating of
Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to
attraction during brain development. Neuron 56, 807–822.
Comeau, M.R., Johnson, R., DuBose, R.F., Petersen, M., Gearing, P.,
VandenBos, T., Park, L., Farrah, T., Buller, R.M., Cohen, J.I., et al. (1998). A
poxvirus-encoded semaphorin induces cytokine production from monocytes
and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8,
473–482.
Donath, M.Y., and Shoelson, S.E. (2011). Type 2 diabetes as an inflammatory
disease. Nat. Rev. Immunol. 11, 98–107.
Edwards, M.G., Anderson, R.M., Yuan, M., Kendziorski, C.M., Weindruch, R.,
and Prolla, T.A. (2007). Gene expression profiling of aging reveals activation of
a p53-mediated transcriptional program. BMC Genomics 8, 80.
Falk, J., Bechara, A., Fiore, R., Nawabi, H., Zhou, H., Hoyo-Becerra, C., Bozon,
M., Rougon, G., Grumet, M., Pu¨schel, A.W., et al. (2005). Dual functional activ-
ity of semaphorin 3B is required for positioning the anterior commissure.
Neuron 48, 63–75.
Fukuda, T., Takeda, S., Xu, R., Ochi, H., Sunamura, S., Sato, T., Shibata, S.,
Yoshida, Y., Gu, Z., Kimura, A., et al. (2013). Sema3A regulates bone-mass
accrual through sensory innervations. Nature 497, 490–493.
Fukushima, Y., Okada, M., Kataoka, H., Hirashima, M., Yoshida, Y., Mann, F.,
Gomi, F., Nishida, K., Nishikawa, S., and Uemura, A. (2011). Sema3E-PlexinD1
signaling selectively suppresses disoriented angiogenesis in ischemic retinop-
athy in mice. J. Clin. Invest. 121, 1974–1985.
Furukawa, S., Fujita, T., Shimabukuro,M., Iwaki, M., Yamada, Y., Nakajima, Y.,
Nakayama, O., Makishima, M., Matsuda, M., and Shimomura, I. (2004).
Increased oxidative stress in obesity and its impact on metabolic syndrome.
J. Clin. Invest. 114, 1752–1761.
Futamura, M., Kamino, H., Miyamoto, Y., Kitamura, N., Nakamura, Y., Ohnishi,
S., Masuda, Y., and Arakawa, H. (2007). Possible role of semaphorin 3F, a
candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angio-
genesis suppression. Cancer Res. 67, 1451–1460.
Gay, C.M., Zygmunt, T., and Torres-Va´zquez, J. (2011). Diverse functions for
the semaphorin receptor PlexinD1 in development and disease. Dev. Biol.
349, 1–19.Metabolism 18, 491–504, October 1, 2013 ª2013 Elsevier Inc. 503
Cell Metabolism
Semaphorin in Adipose TissueGordon, S. (2007). Macrophage heterogeneity and tissue lipids. J. Clin. Invest.
117, 89–93.
Gu, C., Yoshida, Y., Livet, J., Reimert, D.V., Mann, F., Merte, J., Henderson,
C.E., Jessell, T.M., Kolodkin, A.L., and Ginty, D.D. (2005). Semaphorin 3E
and plexin-D1 control vascular pattern independently of neuropilins. Science
307, 265–268.
Hotamisligil, G.S. (2006). Inflammation and metabolic disorders. Nature 444,
860–867.
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N.,
Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al.
(2006). Overexpression of monocyte chemoattractant protein-1 in adipose tis-
sues causes macrophage recruitment and insulin resistance. J. Biol. Chem.
281, 26602–26614.
Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa,
S., Miyachi, H., Maeda, S., Egashira, K., and Kasuga, M. (2006). MCP-1 con-
tributes to macrophage infiltration into adipose tissue, insulin resistance, and
hepatic steatosis in obesity. J. Clin. Invest. 116, 1494–1505.
Kruger, R.P., Aurandt, J., and Guan, K.L. (2005). Semaphorins command cells
to move. Nat. Rev. Mol. Cell Biol. 6, 789–800.
Lin, Y., Berg, A.H., Iyengar, P., Lam, T.K., Giacca, A., Combs, T.P., Rajala,
M.W., Du, X., Rollman, B., Li, W., et al. (2005). The hyperglycemia-induced in-
flammatory response in adipocytes: the role of reactive oxygen species.
J. Biol. Chem. 280, 4617–4626.
Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007). Obesity induces a pheno-
typic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117,
175–184.
Lumeng, C.N., DelProposto, J.B., Westcott, D.J., and Saltiel, A.R. (2008).
Phenotypic switching of adipose tissue macrophages with obesity is gener-
ated by spatiotemporal differences in macrophage subtypes. Diabetes 57,
3239–3246.
Luo, Y., Raible, D., and Raper, J.A. (1993). Collapsin: a protein in brain that in-
duces the collapse and paralysis of neuronal growth cones. Cell 75, 217–227.
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T.,
Sutherland, A., Thorner, M., and Scrable, H. (2004). Modulation of mammalian
life span by the short isoform of p53. Genes Dev. 18, 306–319.
Meek, D.W. (2009). Tumour suppression by p53: a role for the DNA damage
response? Nat. Rev. Cancer 9, 714–723.
Minamino, T., and Komuro, I. (2007). Vascular cell senescence: contribution to
atherosclerosis. Circ. Res. 100, 15–26.
Minamino, T., and Komuro, I. (2008). Vascular aging: insights from studies on
cellular senescence, stem cell aging, and progeroid syndromes. Nat. Clin.
Pract. Cardiovasc. Med. 5, 637–648.
Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T.,
Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., et al. (2009). A crucial role
for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15,
1082–1087.
Moriya, J., Minamino, T., Tateno, K., Okada, S., Uemura, A., Shimizu, I.,
Yokoyama, M., Nojima, A., Okada, M., Koga, H., and Komuro, I. (2010).
Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Circ. Res. 106, 391–398.
Ochi, K., Mori, T., Toyama, Y., Nakamura, Y., and Arakawa, H. (2002).
Identification of semaphorin3B as a direct target of p53. Neoplasia 4, 82–87.
Odegaard, J.I., and Chawla, A. (2013). Pleiotropic actions of insulin resistance
and inflammation in metabolic homeostasis. Science 339, 172–177.
Ohta, K., Mizutani, A., Kawakami, A., Murakami, Y., Kasuya, Y., Takagi, S.,
Tanaka, H., and Fujisawa, H. (1995). Plexin: a novel neuronal cell surfacemole-
cule that mediates cell adhesion via a homophilic binding mechanism in the
presence of calcium ions. Neuron 14, 1189–1199.
Ouchi, N., Parker, J.L., Lugus, J.J., andWalsh, K. (2011). Adipokines in inflam-
mation and metabolic disease. Nat. Rev. Immunol. 11, 85–97.504 Cell Metabolism 18, 491–504, October 1, 2013 ª2013 Elsevier InPera¨la¨, N., Sariola, H., and Immonen, T. (2012). More than nervous: the
emerging roles of plexins. Differentiation 83, 77–91.
Roodink, I., Kats, G., van Kempen, L., Grunberg, M., Maass, C., Verrijp, K.,
Raats, J., and Leenders, W. (2008). Semaphorin 3E expression correlates
inversely with Plexin D1 during tumor progression. Am. J. Pathol. 173, 1873–
1881.
Roth, L., Koncina, E., Satkauskas, S., Cre´mel, G., Aunis, D., and Bagnard, D.
(2009). The many faces of semaphorins: from development to pathology. Cell.
Mol. Life Sci. 66, 649–666.
Sakurai, A., Gavard, J., Annas-Linhares, Y., Basile, J.R., Amornphimoltham,
P., Palmby, T.R., Yagi, H., Zhang, F., Randazzo, P.A., Li, X., et al. (2010).
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regu-
lating Arf6 and R-Ras. Mol. Cell. Biol. 30, 3086–3098.
Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa,
H., Tateno, K., Kayama, Y., Harada, M., et al. (2007). p53-induced inhibition of
Hif-1 causes cardiac dysfunction during pressure overload. Nature 446,
444–448.
Schenk, S., Saberi, M., and Olefsky, J.M. (2008). Insulin sensitivity: modulation
by nutrients and inflammation. J. Clin. Invest. 118, 2992–3002.
Song, H., Ming, G., He, Z., Lehmann, M., McKerracher, L., Tessier-Lavigne,
M., and Poo, M. (1998). Conversion of neuronal growth cone responses from
repulsion to attraction by cyclic nucleotides. Science 281, 1515–1518.
Sun, K., Kusminski, C.M., and Scherer, P.E. (2011). Adipose tissue remodeling
and obesity. J. Clin. Invest. 121, 2094–2101.
Suzuki, K., Kumanogoh, A., and Kikutani, H. (2008). Semaphorins and their
receptors in immune cell interactions. Nat. Immunol. 9, 17–23.
Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G.I., Song, H., Chedotal,
A., Winberg, M.L., Goodman, C.S., Poo, M., et al. (1999). Plexins are a large
family of receptors for transmembrane, secreted, and GPI-anchored sema-
phorins in vertebrates. Cell 99, 71–80.
Tchkonia, T., Morbeck, D.E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J.,
Scrable, H., Khosla, S., Jensen, M.D., and Kirkland, J.L. (2010). Fat tissue,
aging, and cellular senescence. Aging Cell 9, 667–684.
Tran, T.S., Kolodkin, A.L., and Bharadwaj, R. (2007). Semaphorin regulation of
cellular morphology. Annu. Rev. Cell Dev. Biol. 23, 263–292.
Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N.,
Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002). p53
mutant mice that display early ageing-associated phenotypes. Nature 415,
45–53.
Van Gaal, L.F., Mertens, I.L., and De Block, C.E. (2006). Mechanisms linking
obesity with cardiovascular disease. Nature 444, 875–880.
Vousden, K.H., and Lane, D.P. (2007). p53 in health and disease. Nat. Rev.
Mol. Cell Biol. 8, 275–283.
Vousden, K.H., and Ryan, K.M. (2009). p53 and metabolism. Nat. Rev. Cancer
9, 691–700.
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and
Ferrante, A.W., Jr. (2003). Obesity is associated with macrophage accumula-
tion in adipose tissue. J. Clin. Invest. 112, 1796–1808.
Yanovski, S.Z., and Yanovski, J.A. (2002). Obesity. N. Engl. J. Med. 346,
591–602.
Ye, J., Gao, Z., Yin, J., and He, Q. (2007). Hypoxia is a potential risk factor for
chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and
dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293, E1118–E1128.
Zeyda, M., and Stulnig, T.M. (2007). Adipose tissue macrophages. Immunol.
Lett. 112, 61–67.
Zhou, Y., Gunput, R.A., and Pasterkamp, R.J. (2008). Semaphorin signaling:
progress made and promises ahead. Trends Biochem. Sci. 33, 161–170.c.
